Home				Orphan Diseases Drug Development Weekly - Y2007 week 02
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
01/12/07	Jazz Pharmaceuticals (US)	Valeant Pharmaceuticals (US)	Narcolepsy - cataplexy	Jazz Pharmaceuticals Signs Licensing Agreement With Valeant Pharmaceuticals for Canadian Marketing Rights to Xyrem(R)
01/12/07	Valeant Pharmaceuticals (US)	Jazz Pharmaceuticals (US)	Narcolepsy - cataplexy	Valeant Pharmaceuticals Signs Licensing Agreement for Canadian Rights to (C)Xyrem® (Sodium Oxybate) from Jazz Pharmaceuticals
01/09/07	Actelion (CH)	CoTherix (US)	Pulmonary arterial hypertension	Actelion Ltd. Announces Successful Completion of its Cash Tender Offer for Shares of CoTherix, Inc.
01/09/07	GlaxoSmithKline (US)	Praecis Pharmaceuticals (US)	Non-Hodgkin's lymphoma	GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS
01/08/07	Seattle Genetics (US)	Genentech (US)	Various	Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40